Dr. John Caulfield

Doctor John Caulfield was a member of the AI Development Team during its work on Project Paidion and later worked on projects in Minos Tower.

Season Two
Dr. Caulfield features in a subplot around Resident Cassandra Morris. His name is first mentioned in "Questions", where she becomes Dr. Caulfield's assistant when she transfers to Minos from Argos Tower. During his conversation with SAYER in "Another Unfortunate Paradox", it is implied that Dr. Caulfield has taken interest in Argos Tower (in part because of Resident Morris) and has submitted a proposal to conduct some kind of large-scale research project on it. The experiment that she is conducting on him in that episode seems to have been influenced by the knowledge of what this project is. Later, in "Substantial Mutual Harm" it seems that she has requested a transfer of a personal friend of hers away from Argos, and that Dr. Caulfield has signed off on this request.

Season Five
Dr. Caulfield does not appear on air in Season Five, but is the subject of some of Dr. Brady's frustrations in "Developer's Log". He had begun disabling protocols on a "sandboxed S8 subversion," causing a disruption that cost the team time. Dr. Caulfield was apparently given his own access to this subversion (and the rest of the team, presumably, made another) to continue to play with it and hopefully find something that would prove useful in the final development of FUTURE.

Personality
Dr. Caulfield is described by Dr. Brady as being "hard to read." He also says that Dr. Caulfield has a tendency to keep to himself, which the rest of team prefers.

He seems prone to humanizing SAYER and attributing emotions to it. He asks such questions as whether it is enjoying its work with or if it has grown fond of Argos Tower.

Trivia

 * By combining information in the comic 'Welcome to Typhon' and information from Season 5, it can be inferred that Dr. Caulfield was at least a Tier 5 resident during FUTURE's development. However information from the comic is only semi-canonical.